Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: Next-Generation Diagnostics Offer On-the-Spot Results
Dorothy J. Schirf, MD, MDLinx Oncology
Off-Label Use: Sitting In Limbo
Roberta Buell, MBA, Sausalito Healthcare Partners
Clinical Trial Watch: Trial Finds Virtual Colonoscopy Comparable to Standard Colonoscopy
Tracy Hampton, PhD, MDLinx Oncology
  See all
diffuse scleroderma; autologous stem cell transplantation Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Autologous stem cell transplantation in diffuse scleroderma: Impact on hand structure and function
Internal Medicine Journal, 07/09/08
Print     Email This Article     Save in My Library   Free Abstract
Englert H et al. - Autologous stem cell transplantation (ASCT) improved hand scleroderma over 12 months and resolved previously refractory tenosynovitis. Loss of finger abduction was a more sensitive measure of finger clawing than apparent loss of hand length.

Methods
  • Study to assess the structural and functional effects of autologous ASCT on scleroderma finger clawing
  • Photocopies of hands of 5 scleroderma pts who underwent ASCT were used
  • Functional assessments used a standardized questionnaire

Results
  • Pre-ASCT, synovitis and tenosynovitis were present in 5 and 4 pts, respectively
  • Modified Rodnan hand skin scores ranged from 6–12/12
  • Following pulsed chemotherapy, synovitis resolved; tenosynovitis often did not
  • Post-ASCT, skin scores fell in 4 pts (range 0–6/12)
  • Hand tenosynovitis resolved
  • With disease remission hand function globally improved
  • Functional improvement, noted early (+3 mos) and continuously (+12 mos) in disease remitters, occurred in all areas of function
  • The 2-5 metacarpophalangeal width was reproducible and independent of ASCT therapy
  • In contrast, hand length and measures of abducted finger span (1-5 fingertip and 2-5 fingertip distance) improved
  • Finger abduction (abducted 1-5 fingertips/2-5 metacarpophalangeal width) was a more sensitive discriminator of finger clawing than hand length or hand length/2-5 metacarpophalangeal width

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.